-+ 0.00%
-+ 0.00%
-+ 0.00%

Anebulo Pharmaceuticals Q3 EPS $(0.04) Beats $(0.05) Estimate

Benzinga·05/13/2025 22:26:23
Listen to the news
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 33.33 percent increase over losses of $(0.06) per share from the same period last year.